Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Femasys Inc FEMY

Healthcare Medical Devices
Femasys Inc. is a biomedical company. The Company is focused on addressing the unmet needs of women worldwide with a broad portfolio of in-office, accessible, and therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:FEMY)

Femasys Advances Global Growth with Second Partner Order for FemBloc® in Europe

GlobeNewswire 3 days ago

Femasys Secures FDA Approval to Advance Final FemBloc® Trial Phase and $12 Million Financing, with Potential to Reach $58 Million

GlobeNewswire 10 days ago

Femasys Announces Initiation of Post-Market Surveillance Study for FemBloc® Permanent Birth Control in Europe

GlobeNewswire October 22, 2025

Femasys to Exhibit at the ASRM 2025 Scientific Congress & Expo

GlobeNewswire October 16, 2025

Femasys Accelerates European Growth for FemBloc® with Kebomed Partnership

GlobeNewswire September 25, 2025

Femasys Partners with Medical Electronic Systems to Launch FemSperm(TM) Analysis Kit for use with FemaSeed

GlobeNewswire September 22, 2025

Femasys Expands FemSperm(TM) Product Line with New Insemination Prep Kit to Broaden Gynecology-Based Access to FemaSeed®

GlobeNewswire September 11, 2025

Femasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New Zealand

GlobeNewswire September 8, 2025

Femasys Closes $8 Million in Financing to Accelerate Commercialization of Fertility and Birth Control Portfolios

GlobeNewswire September 2, 2025
View More News ››

Opinion & Analysis (NDAQ:FEMY)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:FEMY)

What is new?

Good week?
Tulsa123 - December 15, 2024

FEMY....On watch at $2.12....NR

  Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility...
Iseneschal - March 20, 2024

FEMY ..... What a shame

totally missed this one Surpassing my expectations for sure !!!!
Iseneschal - September 29, 2023

FEMY..... movin

No position
Iseneschal - September 28, 2023

FEMY.....yesterdays chasers have all been had....again

What a game !!!!!
Iseneschal - September 27, 2023

FEMY.....LoL

Sold into that pop Cheers !
Iseneschal - September 26, 2023
View more Bullboard ››

Antimony Resources Corp

Antimony Resources Corp

Antimony Resources Corp., formerly Big Red Mining Corp., is a Canada-based company. The Company holds an option to acquire a ...
View More »